Blinatumomab Treatment

DRUG2 trials

Sponsors

The Children's Hospital of Zhejiang University School of Medicine, West China Hospital

Conditions

ABO Blood Type Incompatible Kidney TransplantationCNI-intolerentCNI-resistant Steriod Resistant Nephrotic SyndromeMultidrug Resistant Nephrotic SyndromeSteriod Resistant Nephrotic Syndrome

Early Phase 1

Safety and Efficacy of the Bispecific T-Cell Engager (BiTE) as Conditioning Regimen for ABO-incompatible Living Donor Kidney Transplantation

Not yet recruitingNCT07706205

West China HospitalABO Blood Type Incompatible Kidney Transplantation

Start: 2026-09-01End: 2028-12-31Target: 20Updated: 2026-07-15

Phase 1

Blinatumomab for CNI-Resistant/Intolerant SRNS in Children

RecruitingNCT06607991

The Children's Hospital of Zhejiang University School of MedicineCNI-intolerent, CNI-resistant Steriod Resistant Nephrotic Syndrome, Multidrug Resistant Nephrotic Syndrome +1

Start: 2024-09-19End: 2027-09-18Target: 6Updated: 2025-08-06